PedAM
Pediatric Disease Annotations & Medicines
| Disease | atrial fibrillation |
| Phenotype | C0040053|thrombosis |
| Sentences | 11 |
| PubMedID- 25861354 | Warfarin is a common anticoagulant agent that is used in various cardiovascular diseases, venous thrombosis, prevention of systematic embolism, atrial fibrillation, and cardiac valve diseases [1]. |
| PubMedID- 19178964 | Background: the association between inflammatory status and thrombosis in patients with atrial fibrillation (af) is unclear. |
| PubMedID- 24681012 | Radiotherapy and prevention of thrombosis in a patient with atrial fibrillation. |
| PubMedID- 20082208 | Advanced age, low left atrial appendage velocity, and factor v promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation. |
| PubMedID- 23023369 | It is approved in the united states for the prophylaxis of deep vein thrombosis and stroke in patients with atrial fibrillation; however, it also carries a black box warning regarding the risk of thrombosis after discontinuation of treatment. |
| PubMedID- 21925716 | This study investigated the antithrombotic effect of azd0837, compared to ximelagatran and the vitamin k antagonist (vka) phenprocoumon (marcoumar), in a disease model of thrombosis in patients with non-valvular atrial fibrillation (nvaf). |
| PubMedID- 24057604 | Abo blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey. |
| PubMedID- 23497203 | Oral anticoagulant therapy (oat) is used to prevent thrombosis in patients with atrial fibrillation (af), venous thrombosis and prosthetic heart valves. |
| PubMedID- 21828929 | Triple-chamber cardiac thrombosis in a patient with atrial fibrillation and severe left ventricular dysfunction. |
| PubMedID- 23026659 | Orally active direct inhibitors of thrombin and factor xa have now been approved for treatment or prevention of deep vein thrombosis,and stroke associated with atrial fibrillation. |
| PubMedID- 23411574 | Because the left atrial appendix (laa) is the most common place of thrombosis formation in patients with atrial fibrillation (af) and mitral stenosis (ms), it can easily be excluded from the systemic circulation at the time of cardiac surgery by excision, ligation, suturing, or stapling. |
Page: 1